Veals J W, Korduba C A, Symchowicz S
Eur J Pharmacol. 1977 Feb 7;41(3):291-9. doi: 10.1016/0014-2999(77)90322-3.
Chronic (6 days) dexamethasone administration caused a slight decrease of rat brain MAO enzyme activity which was reflected by lower levels of 14C-homovanillic acid (HVA) and increased levels of 14C-3-methoxytyramine (3MT) following intracisternal injections of 14C-dopamine (DA). Opposite results with dexamethasone were obtained in iproniazid (MAO-inhibited)-treated rats. In these animals, brain MAO enzyme activity was significantly increased by dexamethasone. This effect increased with the duration of dexamethasone treatment and appeared to be dose dependent. In the brain areas tested (hypothalamus, midbrain, cerebellum, pons and medulla, olfactory, rest of brain) increases of MAO enzyme activity were also indicated by lower levels of 14C-3MT and increased levels of 14C-HVA formed from intracisternally injected radiolabeled DA. Treatment with other glucocorticoids (16alpha-methyldichlorisone, 16beta-methylprednisone and prednisolone) had a similar effect on 14C-DA metabolism. On the other hand, desoxycorticosterone, progestone, estradiol and testosterone, did not exhibit this property. The data indicate that chronic glucocorticoid treatment may have a slight inhibitory effect on brain MAO and also has the ability to partially reverse or antagonize the inhibition of MAO caused by iproniazid.
慢性(6天)给予地塞米松会导致大鼠脑单胺氧化酶(MAO)活性略有下降,这在脑池内注射14C - 多巴胺(DA)后,表现为14C - 高香草酸(HVA)水平降低以及14C - 3 - 甲氧基酪胺(3MT)水平升高。在接受异烟肼(MAO抑制剂)治疗的大鼠中,地塞米松产生了相反的结果。在这些动物中,地塞米松显著提高了脑MAO酶活性。这种效应随着地塞米松治疗时间的延长而增强,并且似乎具有剂量依赖性。在所测试的脑区(下丘脑、中脑、小脑、脑桥和延髓、嗅球、脑的其余部分)中,脑池内注射放射性标记的DA后形成的14C - 3MT水平降低以及14C - HVA水平升高也表明MAO酶活性增加。用其他糖皮质激素(16α - 甲基二氯米松、16β - 甲基泼尼松和泼尼松龙)治疗对14C - DA代谢有类似影响。另一方面,脱氧皮质酮、孕酮、雌二醇和睾酮则没有表现出这种特性。数据表明,慢性糖皮质激素治疗可能对脑MAO有轻微抑制作用,并且还具有部分逆转或拮抗异烟肼引起的MAO抑制的能力。